文献速递肝病

迈向非酒精性脂肪性肝病轨迹的遗传预测:PNPLA3及更多

Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond.
PubMed 文献 · Gastroenterology · 2020-02-15

非酒精性脂肪性肝病(NAFLD)正成为主要肝病,由环境与遗传易感交互作用所致。全基因组关联研究及外显子组分析识别出PNPLA3、TM6SF2、SERPINA1等遗传风险变异及关键通路,功能研究阐明了从脂肪堆积到纤维化、肝硬化和癌症的分子机制。本文总结关键NAFLD风险基因,并在三维「风险空间」中展示其相互作用,展望其在试验设计、结局预测和监测中的临床效用。

要点

  • NAFLD发生源于环境因素与遗传易感的交互作用。
  • 已识别PNPLA3、TM6SF2、SERPINA1等遗传风险变异及关键通路。
  • 遗传信息有望用于试验设计、结局预测和NAFLD监测。

核心结论

  • NAFLD基因组学在试验设计、结局预测和监测方面具有临床转化潜力。

研究设计与样本

  • 本文为综述,总结NAFLD关键风险基因及其在三维「风险空间」中的相互作用。

主要发现

  • 全基因组关联研究及外显子组分析识别出PNPLA3、TM6SF2、SERPINA1等遗传风险变异和关键通路。
  • 功能研究增进了对从脂肪堆积到纤维化、肝硬化和癌症轨迹的分子机制的理解。

临床怎么用

  • 可将遗传风险变异信息用于NAFLD的试验设计、结局预测和监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nonalcoholic fatty liver disease (NAFLD) is on the verge of becoming the leading cause of liver disease. NAFLD develops at the interface between environmental factors and inherited predisposition. Genome-wide association studies, followed by exome-wide analyses, led to identification of genetic risk variants (eg, PNPLA3, TM6SF2, and SERPINA1) and key pathways involved in fatty liver disease pathobiology. Functional studies improved our understanding of these genetic factors and the molecular mechanisms underlying the trajectories from fat accumulation to fibrosis, cirrhosis, and cancer over time. Here, we summarize key NAFLD risk genes and illustrate their interactions in a 3-dimensional "risk space." Although NAFLD genomics sometimes appears to be "lost in translation," we envision clinical utility in trial design, outcome prediction, and NAFLD surveillance.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Krawczyk M, Liebe R, Lammert F, et al. Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond. Gastroenterology. 2020. PMID: 32068025. doi:10.1053/j.gastro.2020.01.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。